FY25 Annual Report
12 Sep 2025
FY25 Appendix 4G and Corporate Governance Statement
12 Sep 2025
FY25 Results
29 Aug 2025
FY25 Results Presentation
29 Aug 2025
FY25 Appendix 4E Preliminary Final Report
29 Aug 2025
FY25 Results Presentation Notification
27 Aug 2025
Notification of cessation of securities – BUB
26 Aug 2025
CEO Appointment Joe Coote
28 Jul 2025
Quarterly Activities/Appendix 4C Cash Flow Report
28 Jul 2025
BUBS SUBMITS CLINICAL TRIAL DATA TO US FDA
16 Jun 2025
Alpha Group Legal Dispute
29 Apr 2025
Q3 FY25 Quarterly Activities Report and Appendix 4C Cashflow Statement
28 Apr 2025
View all announcements